43

Listed companies

21

Private companies

78

Insiders

Relation chart of related listed companies: Moderna, Inc.

Active Relations

Past Relations

Related listed companies: Moderna, Inc.

Active Relations

Past Relations

Relationship chart for related private companies: Moderna, Inc.

Active Relations

Past Relations

Related private companies: Moderna, Inc.

Ring Therapeutics, Inc.

Pharmaceuticals: Major

Harvard University

Other Consumer Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

YourBio Health, Inc.

Electronic Equipment/Instruments

Inzen Therapeutics, Inc.

Biotechnology

Massachusetts Institute of Technology

Finance/Rental/Leasing

Qiagen SRL

Medical Specialties

Tessera Therapeutics, Inc.

Biotechnology

Indigo Ag, Inc.

Biotechnology

David H. Koch Institute for Integrative Cancer Research

Miscellaneous Commercial Services

QIAGEN GmbH

Miscellaneous Commercial Services

Generate Biomedicines, Inc.

Biotechnology

National Academy of Medicine (United States)

Miscellaneous Commercial Services

Longwood Fund Management LLC

Investment Managers

American Bar Association

Miscellaneous Commercial Services

Empress Therapeutics, Inc.

Pharmaceuticals: Major

TARIS BioMedical LLC

Pharmaceuticals: Major

Repertoire Immune Medicines, Inc.

Miscellaneous Commercial Services

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Biotechnology26
Pharmaceuticals: Major11
Miscellaneous Commercial Services7
Medical Specialties4
Investment Managers3
Finance/Rental/Leasing1
Managed Health Care1
Information Technology Services1
Pharmaceuticals: Generic1
Medical Distributors1

Countries of related companies

United States52
Ireland3
Switzerland2
United Kingdom2
Germany1
Italy1
South Korea1
Israel1
Netherlands1
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (97.4%); - grant revenue (1.4%); - revenue from collaboration agreements (1.2%). At the end of 2023, the group possessed a portfolio of 41 products in clinical development, of which 6 in phase III, 12 in phase II and 18 in phase I, and 5 products in preclinical development. Net sales are distributed geographically as follows: the United States (27.7%), Europe (19.8%) and other (52.5%).
Employees
5,600
Calendar
More about the company